N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain

James D. Pomonis, James Harrison, Lilly Mark, David R. Bristol, Kenneth J. Valenzano, Katharine Walker

Journal of Pharmacology and Experimental Therapeutics · 2003 · 261 citations · 38 references

Concepts

References

38